THE EFFECT OF FOLIC ACID SUPPLEMENTATION IN BETA-THALASSEMIA MAJOR: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOJTAHEDZADEH F.; KOUSARIAN M.; MAHDAVI M.R.; AKBARI J.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARCHIVES OF IRANIAN MEDICINE Year:2006 | Volume:9 | Issue:3 Page(s): 266-268

Download Full-Text

View:

684

Download:

735

Cites:

Information Journal Paper

Title

THE EFFECT OF FOLIC ACID SUPPLEMENTATION IN BETA-THALASSEMIA MAJOR: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL

Author(s)

MOJTAHEDZADEH F. | KOUSARIAN M. | MAHDAVI M.R. | AKBARI J. | Issue Writer Certificate

Keywords

BETA-THALASSEMIA MAJOR (THALASSEMIA MAJOR)

DEFICIENCY

FOLIC ACID

MAZANDARAN

TREATMENT

Abstract

Folic acid is a coenzyme for many important biochemical reactions including synthesis of purines, pyrimidines, and nucleoproteins. The recommended daily allowance of FOLIC ACID is 65 – 200 µg/day for infants and children. The recommended dose for DEFICIENCY states is 1000 µg/day; the effects of excess amounts of FOLIC ACID are unknown. The role of FOLIC ACID in preventing progression of arteriosclerosis is rather a new issue. Thrombotic events related to slightly elevated levels of homocystein in adults may be decreased by daily consumption of 1 mg of FOLIC ACID together with 5 – 100 mg of pyridoxine.

Cites

SCREENING AND IDENTIFYING OF ERYTHROCYTE ALLOANTIBODIES IN PATIENTS WITH THALASSEMIA MAJOR REFERRED TO AHVAZ SHAFA HOSPITAL

References

No record.

Cite

APA: Copy

MOJTAHEDZADEH, F., KOUSARIAN, M., MAHDAVI, M.R., & AKBARI, J.. (2006). THE EFFECT OF FOLIC ACID SUPPLEMENTATION IN BETA-THALASSEMIA MAJOR: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL. ARCHIVES OF IRANIAN MEDICINE, 9(3), 266-268. SID. https://sid.ir/paper/280115/en

Vancouver: Copy

MOJTAHEDZADEH F., KOUSARIAN M., MAHDAVI M.R., AKBARI J.. THE EFFECT OF FOLIC ACID SUPPLEMENTATION IN BETA-THALASSEMIA MAJOR: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2006;9(3):266-268. Available from: https://sid.ir/paper/280115/en

IEEE: Copy

F. MOJTAHEDZADEH, M. KOUSARIAN, M.R. MAHDAVI, and J. AKBARI, “THE EFFECT OF FOLIC ACID SUPPLEMENTATION IN BETA-THALASSEMIA MAJOR: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL,” ARCHIVES OF IRANIAN MEDICINE, vol. 9, no. 3, pp. 266–268, 2006, [Online]. Available: https://sid.ir/paper/280115/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops